Both in Biotechnology
Century Therapeutics vs Ocugen
Over the past year IPSC returned +142.0% and OCGN returned −48.9%; their daily moves had a correlation of 0.14.
IPSC +142.0% OCGN −48.9%Growth of $1, one year, split-adjusted
| Metric | IPSC | OCGN |
|---|---|---|
| Price | $1.47 | $0.7551 |
| Market cap | $266.2M | $256.1M |
| Today | +1.38% | −0.30% |
| 1 month | −10.9% | −30.7% |
| 6 months | −33.2% | −55.1% |
| Year to date | +47.8% | −44.1% |
| 1 year | +145.0% | −51.6% |
| Revenue growth (YoY) | — | +8.4% |
| Gross margin | — | 100.0% |
| Net margin | — | −1671.8% |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $119.7M | $15.9M |
| Dividend yield | — | — |
| Volatility (60d) | 73.2% | 69.9% |
| Short % of float | 23.4% | 33.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).